###### Key questions

What is already known about this subject?
=========================================

-   Patient delay with symptoms of time-critical conditions like acute coronary syndrome (ACS) remains a worldwide problem.

-   Interventions to reduce delay have had mixed results.

-   Embedding behaviour change techniques (BCTs) within interventions might be important in relation to effectiveness.

What does this study add?
=========================

-   This systematic review has found that only half of the interventions to reduce prehospital delay with time-critical symptoms report significantly reduced delay times.

-   It is unclear what differentiates effective from non-effective interventions.

-   However, some limited evidence suggests that additional use of BCTs might be helpful in reducing patient delay in particular.

How might this impact on clinical practice?
===========================================

-   Our results suggest that the development of interventions that incorporate more BCTs might be a promising next step in addressing the important and long-standing problem of patient delay with time-critical symptoms.

-   If interventions could be developed that successfully reduce patient delay, they have the potential to significantly reduce mortality and morbidity from ACS and other time-critical conditions.

Introduction {#s1}
============

It has long been recognised that time to treatment in acute coronary syndrome (ACS) is critical to reducing mortality.[@R1] Contemporary healthcare systems and pathways are designed to facilitate immediate assessment and care where ACS is suspected.[@R2] This often includes an emergency telephone service, rapid response by paramedic, transfer to hospital by ambulance, immediate triage, and prompt initiation of reperfusion treatments such as percutaneous coronary intervention or thrombolysis.[@R3] Much has been achieved and continues to be achieved by improving emergency care services. Mortality from cardiovascular disease has declined dramatically in the last 30 years in the UK[@R5] and other high-income countries,[@R6] with 8% of the reduction attributed to initial treatment of acute myocardial infarction.[@R7] European registry data show continuing improvements in hospital reperfusion times as well as reduced mortality for people with ACS.[@R8]

Despite the achievements in emergency care, delays between onset of symptoms and receipt of treatment persist.[@R9] Recently, an Irish study[@R10] reported median delay times of more than 7 hours in their control group. The largest interval in pretreatment time has been identified as '*patient decision time'*.[@R11] Patient decision time (often referred to as 'patient delay') refers to the interval between onset of symptoms and seeking medical help and has proved much more challenging to reduce than other components of delay, such as transportation and hospital delays, also referred to as utilisation delay.[@R12] However, if reductions in patient delay could be achieved, they offer the potential to lead to significant reductions in mortality for ACS.[@R13]

A number of interventions aimed at reducing patient delay times for ACS have been trialled, but to date the pattern of results is mixed. A systematic review which focused on mass media interventions to reduce delay concluded that they had little success in changing behaviour.[@R14] More recently, an alternative strategy of intensive, targeted interventions for people at high risk of ACS (those with existing coronary heart disease) has been trialled in the USA[@R15] and Ireland.[@R10] The two interventions were strikingly similar, both described as comprising an individualised, one-on-one session of approximately 30--40 min with the patient and significant other, with a 15 min follow-up phone call. Both studies cite Leventhal's theory of self-regulation as the underlying theoretical framework and provide information about symptoms, instructions of how and when to call for help, anticipate and plan for possible emotional responses, involve significant others, encourage significant others to deputise in the event of symptoms, and provide written instructions for participants to take away. However while Mooney *et al* [@R10] found a significant difference postintervention between the intervention and the control group, Dracup *et al* [@R15] did not. Given that two very similar interventions produced very different results, it is yet to be determined what the effective components of an intervention to reduce patient delay are.

There is evidence to suggest that embedding evidence-based behaviour change techniques (BCTs) (eg, goal-setting, action planning)[@R16] within interventions is more likely to lead to successful behaviour change. For example, an intervention using established BCTs has been effective in reducing patients' intended delay time with symptoms of lung cancer, another time-sensitive condition.[@R17] The publication of the Behaviour Change Techniques Taxonomy V.1 (BCTT V.1)[@R19] provides an opportunity to systematically examine previous interventions to establish which specific BCTs are associated with effective interventions, but to date this has not been undertaken in the context of interventions to reduce patient delay with symptoms of ACS. Patient delay is critical for a range of time-critical conditions, including but not limited to ACS.[@R20] Given that patient perceptions of symptoms guide patient delay, rather than clinician subsequent diagnoses, we examined interventions that target patient recognition and response to acute conditions to maximise learning from the available literature.

Therefore this paper reports the results of a systematic review which for the first time aimed to identify which BCTs are associated with effective interventions to reduce patient delay (or prompt rapid help-seeking) among people with symptoms or conditions where time to treatment is critical.

Methods {#s2}
=======

Protocol and registration {#s2-1}
-------------------------

In line with best practice,[@R21] a review protocol was published in 2014[@R20] and registered with the PROSPERO International prospective register of systematic reviews based at the University of York and can be accessed through the following website: <http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=CRD42014013106>.

Eligibility criteria {#s2-2}
--------------------

Studies were included if they met the following inclusion criteria:

### Types of study {#s2-2-1}

Any intervention study (including randomised controlled trials \[RCTs\], controlled clinical trials and cohort studies) which includes an outcome measure of patient delay/time to presentation with symptoms (ie, behaviour).

### Types of participants {#s2-2-2}

Adults (\>18 years) with symptoms or conditions where time to treatment is critical (ie, timing of presentation has a demonstrated effect on mortality).

### Types of interventions {#s2-2-3}

Any intervention where the stated aim was to reduce patient delay/time to presentation to health services (eg, patient education intervention or multimedia public health campaign).

### Types of outcome measure {#s2-2-4}

To be included, studies had to include a measure of patient delay time (ie, interval between the onset of symptoms and seeking medical help), which is the primary outcome of interest in this review. The following secondary outcomes were also examined: intentions to seek help without delay, number and type of presentations with symptoms (general practitioner \[GP\], hospital, ambulance), and number of deaths and adverse events.

Papers were excluded if they did not report a primary empirical study of an intervention (ie, reviews, editorials, opinion pieces, commentaries, letters to editors, papers describing intervention), did not include a measure of prehospital delay and only included participants \<18 years. Studies were not excluded on the basis of language or year of publication.

Information sources and search strategy {#s2-3}
---------------------------------------

A comprehensive search strategy was developed to identify primary studies evaluating interventions aimed at reducing patient delay. Five electronic databases---Cochrane Library, MEDLINE, EMBASE, Cumulative Index to Nursing and Allied Health Literature, and PsycINFO and the National Research Register (NRR)---were searched independently for publications from inception of each database to 1 August 2016. The search strategy combined terms related to time-critical conditions and patient delay with the AND operator. A third term related to intervention was combined by AND with the above terms to narrow down the search and limit it to studies reporting on an intervention. Both index terms (ie, medical subject headings/subject headings/thesaurus) and free-text keywords were used. The full search strategy is presented in [figure 1](#F1){ref-type="fig"}. The database searches were supplemented with searches through the following other sources: (1) reference lists of all included studies and previous reviews of similar interventions, (2) citations of included studies using three citation index databases (Science Citation Index, Social Sciences Citation Index and Arts, and Humanities Citation Index), (3) National Research Register, and (4) email contact with authors of conference abstracts and of studies identified through the National Research Register to obtain details of ongoing, unpublished or recently completed research.

![Search strategy.](openhrt-2018-000975f01){#F1}

Study selection {#s2-4}
---------------

Initial screening of titles was undertaken by one reviewer (PA) to exclude any that were obviously irrelevant. The reliability of this screening was assessed by a second reviewer (BF) independently screening a subset of the titles. The abstracts of studies included from their titles were then screened independently by two reviewers (PA and BF) applying the inclusion/exclusion criteria. Full texts of the studies that were considered potentially relevant by either reviewer were screened independently by the same reviewers. At the full-text screening stage, any disagreements between the reviewers over inclusion or exclusion were resolved by seeking independent opinion from a third reviewer (SUD). A similar process was applied to the screening of records identified from citation tracking. Studies identified from the reference lists of included studies, previous reviews of similar interventions, author contact and the National Research Register were screened first by abstract and then by full text independently by the two reviewers (PA and BF).

Assessment of methodological quality and risk of bias {#s2-5}
-----------------------------------------------------

Methodological quality of the included studies was assessed using the EPHPP Quality Assessment Tool for Quantitative Studies developed by the Effective Public Health Practice Project (EPHPP), Canada.[@R22] This tool was chosen as it enables assessment of multiple quantitative study designs on a comprehensive set of criteria and is recommended by the Cochrane Handbook for use in reviews of public health and health promotion interventions that use a variety of study designs.[@R23] It enables a rating of strong, moderate or weak on six methodological dimensions that assess the risk of bias: selection bias, allocation bias, control of confounders, blinding of outcome assessors, data collection methods, and withdrawals and dropouts. Ratings on these dimensions feed into a global rating. The tool provides two additional questions, not involved in the global rating, one assesses intervention integrity and the other appropriateness of analysis. The tool has been demonstrated to have content and construct validity and test--retest reliability.[@R24] Using this tool, the included studies were independently assessed by two reviewers (PA and SUD) for methodological quality, with discrepancies being resolved through discussion.

Data extraction {#s2-6}
---------------

Data extraction was performed by one team member (PA) on all studies in English and a German-speaking team member (SUD) on the studies in German. Studies in Norwegian and Swedish were translated by a native Norwegian-Swedish speaker. Guided by the Consolidated Standards of Reporting Trials[@R25] and the Template for Intervention Description and Replication[@R26] guidelines, a data extraction form was developed in MS Excel, piloted on six studies by two reviewers (PA and SUD) and revised to ensure that all essential information was recorded systematically. The form recorded the following information for each included study: study details (author and date, location, study duration, study age, clinical condition, objectives), study methods (design, number of study arms, setting, target population, sample size estimation, sample size actual, sampling and recruitment method, outcomes, outcome definition, analysis, dates of recruitment), details of intervention and comparison (name, theory, materials, provider, setting, delivery format, intensity, tailoring, modifications, planned and actual fidelity assessment), BCTs included in the intervention and comparison conditions, and study results (participant flow, participant characteristics, results for primary and secondary outcomes, ancillary analysis, adverse outcomes, authors' conclusion). To assess the feasibility of meta-analysis, data on mean delay time and SDs (for differences in delay times between before and after, or intervention and control) were extracted where available. A third member of the team (BF) independently performed data extraction on a 20% subset of the included studies (n=5) to assess reliability. No discrepancies in independently extracted data were found.

Identification of BCTs {#s2-7}
----------------------

To identify the BCTs, descriptions of the interventions were coded using the 93-item BCTT V.1.[@R19] The coding was undertaken independently by two health psychologists (PA and SUD). First, the coding of BCTs was piloted on six intervention descriptions, and any discrepancies were discussed and resolved by realigning interpretations. During this pilot, it became apparent that interventions included techniques that were not listed in BCTT V.1---these were captured as '*additional techniques*'. The two BCT coders agreed on their working labels and definitions for additional techniques prior to coding the remaining studies (see [online supplementary appendix 1](#SP1){ref-type="supplementary-material"}). Second, BCTT V.1 along with the additional techniques was applied to intervention descriptions of all remaining studies (n=34). Of these, 28 studies available in English were dual-coded by two independent reviewers and six studies in German were single-coded by one reviewer (SUD).
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From the first 22 dual-coded studies, a total of 58 discrepancies were observed from 2090 instances of coding. The average kappa and prevalence-adjusted and bias-adjusted kappa (PABAK) scores, calculated for the BCTs identified as present in at least four studies by either reviewer, reflected poor agreement (kappa=0.49, PABAK=0.58). As the level of agreement was poor, the discrepancies were examined to determine if they were random or systematic, that is, one reviewer consistently overcoding/undercoding a specific BCT compared with the other. The systematic discrepancies were discussed in terms of differences in interpretations of BCTs (for action planning, information about health consequences, credible source and problem-solving) and resolved through consensus (see [online supplementary file appendix 1](#SP1){ref-type="supplementary-material"}). With agreed interpretation of definitions in mind, both reviewers recoded the interventions independently. Following recoding, a total of 33 discrepancies were observed, but the average kappa and PABAK scores improved to reflect satisfactory levels of agreement (kappa=0.58, PABAK=0.77). The remaining discrepancies were resolved through discussion with a third independent reviewer expert in identification of BCTs (MJ).

Methodological quality {#s2-8}
----------------------

During methodological quality assessment using the EPHPP tool,[@R22] it became apparent that some items of the tool were not applicable to the design of some of the studies and hence were not rated. For uncontrolled before and after studies (n=24), the question on 'confounders'---assessing whether there are important differences between two groups prior to intervention---was not applicable due to a lack of a comparison group. Similarly, the questions on 'withdrawals and drop-outs' and 'intention to treat analysis' were not applicable as the before and after assessments of patient delay were carried out in different groups of people. For controlled before and after studies of public health interventions targeted at the whole community (n=3), the question on 'withdrawals and drop-outs' was not applicable as the people not remaining in the study at final data collection period were not intentional withdrawals or dropouts but those who did not have an 'event' requiring urgent medical help. The EPHPP global ratings were therefore only derived for studies with RCT designs.

Synthesis and analysis {#s2-9}
----------------------

The primary outcome of interest was patient decision time (patient delay). The original review protocol proposed that studies would be analysed narratively, and meta-analyses with subgroup analyses would be conducted where the data were appropriate for such analysis. However the data were not suitable for such meta-analyses as information on means and SDs was missing, data were skewed, and there was significant heterogeneity across studies in terms of study design, intervention target, mode of delivery, target population and assessment of patient delay.

Means with or without SDs were reported in 13 studies. Fifteen of 27 authors of the remaining studies were contacted to request means and SD data. Ten of 15 authors contacted to request these data replied; data were no longer available for 8 studies. Two studies required additional analysis to obtain means and SDs as the data were not normally distributed or the sample sizes were small. For the remainder of studies (n=5), means were derived from the medians, sample size, and first and third quartiles, if reported, using a formula by Wan *et al*.[@R27] This resulted in 18 studies for which means were available, 10 of which also reported SDs (see [table 1](#T1){ref-type="table"}).

###### 

Skewness of patient delay time data in studies that reported means and SD

  Study                          Mean    SD      SD ×2   Likely skewness
  -------------------------- --- ------- ------- ------- -----------------
  Before and after studies                               
   Addo *et al* [@R66]       B   374     512     1024    Skewed
                             A   296.8   356.3   712.6   
   Diercks *et al* [@R56]    B   232     271.3   542.6   Skewed
                             A   224     257.9   515.8   
   Naegeli *et al* [@R63]    B   247     248.4   496.8   Skewed
                             A   223.3   229.8   459.6   
   Wolters *et al* [@R51]    B   810     4176    8352    Skewed
                             A   318     1146    2292    
  Controlled studies                                     
   Dracup *et al* [@R15]     I   257.4   20.40   40.8    Not skewed
                             C   304.8   41.4    82.8    
   Luepker *et al* [@R31]    I   130.2   8.25    16.5    Not skewed
                             C   304.8   41.40   82.8    
   Sun *et al* [@R37]        I   498     348     696     Skewed
                             C   630     390     780     

B-before A-after i-Intervention c- control

In seven studies for which both means and SDs were available, either reported or derived, skewness was estimated using the criterion suggested by Altman and Bland,[@R28] that is, data are likely to be skewed if the mean is smaller than twice the SD. As shown in [table 1](#T1){ref-type="table"}, patient delay time data were likely to be skewed in seven of the ten studies, and we were therefore unable to combine studies into a meta-analysis. Instead, the results are synthesised and presented narratively following guidance on conducting systematic reviews of health promotion and public health interventions.[@R23]

As the main aim of this review was to identify what is effective in reducing patient delay, it was particularly important to examine the studies which measured patient delay distinct from those which measured prehospital time. Studies which measure prehospital time have the potential to both overestimate and underestimate the ability of interventions to reduce patient delay. For example, reductions in other elements of prehospital time such as transportation time might be erroneously attributed to the patient delay intervention (leading to overestimation of its effect), or similarly increases in transportation time could 'cancel out' the benefits of an effective patient delay intervention (underestimation).

Results {#s3}
=======

Original database searches (see [figure 2](#F2){ref-type="fig"}) identified 20 996 citations, with 18 285 remaining after removing the duplicates. Searches through other sources (citation tracking, reference lists, National Research Register, contact with authors in the field) identified 824 additional citations. A total of 19 109 titles were screened. The initial screening of titles identified from database search and citation tracking was undertaken by one reviewer (PA), and the reliability of this screening was assessed by a second reviewer (BF) independently screening a subset of the titles.

![Flow chart of studies screened, excluded and included in review.](openhrt-2018-000975f02){#F2}

Titles identified from database search {#s3-1}
--------------------------------------

Just under 5% (n=909) of the number of titles identified from the database search were double-screened. The first screener included 31 titles and the second included 62, with both agreeing on 19 of those selections (see online supplementary material 1). The overall agreement was 94%. The second screener agreed with 61% (19/31) of the titles selected with the first screener and selected an additional 4.7% (43/909) of the titles. The PABAK was 0.88. After double-screening the abstracts of the 74 titles selected by either reviewer, 5 were selected for full-text review. Of the five papers screened in full, two were included. Extrapolating to the total number of titles identified (n=18 285), it was estimated that had all the identified titles been screened in this way, then no studies would have been missed (see online supplementary material 2).

Titles identified from citation tracking {#s3-2}
----------------------------------------

Twenty per cent (n=145) of the total number of titles identified from citation tracking (n=724) were double-screened. Twelve and 18 titles were selected by the first and the second screeners, respectively, with both agreeing on 11 of those selections. The overall agreement was 94%. The second screener agreed with 91% (11/12) of the titles selected with the first screener and selected an additional 4.8% (7/145) of the titles (PABAK=0.88). On screening the abstracts of the eight titles screeners disagreed on, only one was selected for full-text review. This study was later excluded as it did not involve a comparison group. This suggests that none of the additional titles included by second reviewer alone would have made it to the included studies.

An update search using the same search strategy for articles published between March 2014 and August 2016 was also undertaken (see [figure 3](#F3){ref-type="fig"}). This identified an additional 623 citations after removing the duplicates. The 623 titles were independently screened by PA and BF. Abstracts of all titles considered potentially relevant by either screener were then screened. A total of 97 abstracts were independently screened by both reviewers (PA and BF). Of the nine screened in full, two did not meet one or more of the inclusion criteria and one was not available in full text. One paper reported data from an intervention already included. A total of 5 additional papers were identified, giving a total of 39 studies included in the review (Figure 3).

![Update literature search.](openhrt-2018-000975f03){#F3}

Description of included studies {#s3-3}
-------------------------------

The main characteristics of the 39 included studies are summarised in [online supplementary material 3](#SP1){ref-type="supplementary-material"}. The studies addressed patient delay in a variety of clinical contexts: 16 in acute myocardial infarction, 15 in stroke, 5 in ACS, 2 in cancer and 1 in chest pain. The studies were published between 1973 and 2016 and varied geographically, with 14 studies from the USA or Canada, 6 from Germany, 4 each from the UK and Australia, 2 from Ireland, 2 each from Sweden and Switzerland, 1 each from Norway, Italy, Japan and China, and 1 from multiple countries. The studies were heterogeneous in design: 7 were RCTs[@R10] with individuals or communities as unit of randomisation, 3[@R35] controlled before and after studies, 23 uncontrolled before and after studies, 3[@R38] interrupted time series (ITS), 1 case--control study,[@R42] and 2[@R43] post-test-only studies.

The study population in the majority of studies (n=24) consisted of individuals with a suspected diagnosis, that is, presenting with symptoms suggestive of a relevant life-threatening condition; 15 studies included only those with a confirmed diagnosis. For patient delay time, the 7 RCTs reported on a total of 30 888 participants, while 32 studies with non-randomised designs reported on a total of 169 650 participants. Across all studies that reported this information, the average mean age of participants was 65.6 years (SD=5.08, range=56--77), and an average of 42.5% of the participants were female (range 16%--100%, SD=14.6). In all studies, the data were collected from hospital/outpatients settings, with information obtained mainly from patient medical records or relevant clinical registries. In all studies with before and after designs, prehospital/patient delay time was recorded in different people before and after the intervention.

All studies evaluated interventions aimed at reducing patient delay, that is, the time from onset of symptoms to patients seeking medical help. However, the studies varied in terms of how this delay was measured. Twenty-four studies assessed prehospital delay, that is, the time from symptom onset to arrival at hospital/emergency department/coronary care unit; five[@R36] assessed patient delay, that is, the time from symptom onset to the first medical contact; and five assessed both.[@R44] Five studies did not explicitly report how the delay time was measured.[@R41]

Methodological quality {#s3-4}
----------------------

Overall, the methodological quality of included studies was mixed ([tables 2 and 3](#T2 T3){ref-type="table"}). Seven studies were rated as strong for protection against allocation bias due to their RCT design; most of the remaining were moderately rated due to quasi-experimental designs (controlled or uncontrolled before and after studies, and ITS). Of the seven RCTs, two[@R10] were judged to be strong, three[@R15] were judged moderate and two[@R30] as weak. Of the three controlled before and after studies, one[@R35] study was rated strong on selection bias and data collection methods, with the remainder rated as moderate/weak. All three[@R55] were assessed as moderate on blinding, with two assessed as weak on confounders.

###### 

Methodological quality ratings for included studies (n=39)

  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Author and year                                     Selection bias   Design   Confounders   Blinding   Data collection\   Withdrawals\   EPHPP global\   Total score
                                                                                                         methods            and dropouts   rating          
  --------------------------------------------------- ---------------- -------- ------------- ---------- ------------------ -------------- --------------- -------------
  RCTs (n=7)                                          Of 18                                                                                                

  Blank and Smithkline[@R30] 2002                     1                1        3             3          1                  3              3               12

  Boden-Albala *et* *al*,[@R34] 2015                  2                1        1             2          1                  1              1               8

  Dracup *et al*,[@R15] 2009                          1                1        1             1          3                  1              2               8

  Luepker *et al*,[@R31] 2000                         2                1        1             1          1                  3              2               9

  Meischke *et al*,[@R32] 1997                        3                1        3             1          3                  NA             3               11/15

  Mooney *et al*,[@R10] 2014                          2                1        1             1          1                  1              1               7

  Müller-Nordhorn *et al*,[@R33] 2009                 1                1        1             1          3                  1              2               8

  Controlled before and after studies (n=3)           Of 12                                                                                                

  Morgenstern *et al*,[@R35] 2002                     1                2        3             2          1                  NA             NA              6

  Rowley *et al*,[@R36] 1982                          3                2        NA            2          3                  NA             NA              10

  Xin-gang *et al*,[@R37] 2013                        2                2        3             2          3                  NA             NA              9

  Uncontrolled before and after studies /ITS (n=26)   Of 12                                                                                                

  Addo *et al*,[@R66] 2012                            2                2        NA            2          3                  NA             NA              9

  Alberts *et al*,[@R59] 1992                         2                2        NA            2          3                  NA             NA              9

  Barsan *et al*,[@R60] 1994                          2                2        NA            2          3                  NA             NA              9

  Bett *et al*,[@R45] 2004                            2                2        NA            2          3                  NA             NA              9

  Bett *et al*,[@R46] 1993                            2                2        NA            3          3                  NA             NA              10

  Black and Brown,[@R62] 1973                         2                2        NA            2          3                  3              NA              9

  Breuer *et al*,[@R54] 1999                          1                2        NA            2          3                  NA             NA              8

  Camerlingo *et al*,[@R64] 2014                      2                2        NA            2          3                  NA             NA              9

  Diercks *et al*,[@R56] 2010                         2                2        NA            3          3                  NA             NA              10

  Gaspoz *et al*,[@R48] 1996                          2                2        NA            3          3                  NA             NA              10

  Herlitz *et al*,[@R55] 1992                         2                2        NA            2          3                  NA             NA              9

  Ho *et al*,[@R1] 1989                               3                2        NA            2          3                  3              NA              10

  Hodgson *et al*,[@R38] 2007                         1                2        NA            2          3                  NA             NA              8

  Luiz *et al*,[@R49] 2001                            1                2        NA            2          3                  NA             NA              8

  Maeso-Madronero *et al*,[@R52] 2000                 1                2        NA            3          3                  NA             NA              9

  Mellon *et al*,[@R40] 2014                          2                2        NA            2          3                  NA             NA              9

  Mitic and Perkins,[@R57] 1984                       2                2        NA            2          3                  NA             NA              9

  Moses *et al*,[@R67] 1991                           2                2        NA            2          3                  NA             NA              9

  Naegeli *et al*,[@R63] 2011                         2                2        NA            2          3                  NA             NA              9

  Nishijima *et al*,[@R65] 2016                       2                2        NA            2          3                  NA             NA              9

  Rau *et al*,[@R53] 2008                             1                2        NA            2          3                  NA             NA              8

  Rustige *et al*,[@R41] 1992                         2                2        NA            2          3                  NA             NA              9

  Thomassen *et al*,[@R50] 1999                       3                2        NA            2          3                  NA             NA              10

  Waters *et al*,[@R47] 1983                          1                2        NA            2          3                  NA             NA              8

  Wolters *et al*,[@R51] 2015                         2                2        NA            2          3                  NA             NA              9

  Wright *et al*,[@R58] 2001                          1                2        NA            2          3                  NA             NA              8

  Post-test only (n=2)                                Of 12                                                                                                

  Bray *et al*,[@R44] 2015                            2                3        NA            2          3                  NA             NA              10

  Månsson *et al*,[@R43] 1999                         2                3        NA            3          3                  NA             NA              11

  Case--control study (n=1)                           Of 12                                                                                                

  Tummala and Farshid,[@R42] 2015                     2                2        NA            2          3                  NA             NA              9
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------

As the global rating, following EPHPP guidelines, could not be calculated for studies with non-randomised designs, we also calculated a sum total of the ratings across all dimensions that were applicable to the study design. This total score ranges from 6 to 18 if all six dimensions are applicable and from 4 to 12 if only four dimensions are applicable. Lower scores suggest better overall methodological quality and higher scores suggest poorer quality.

EPHPP, Effective Public Health Practice Project; ITS, interrupted time series; NA, not applicable; RCTs, randomised controlled trials.

###### 

Intervention integrity and consistency ratings for included studies (n=39)

  Author and year                             Integrity   Consistency   Contamination   Unit of allocation   Unit of analysis   Intention To Treat (ITT)
  ------------------------------------------- ----------- ------------- --------------- -------------------- ------------------ --------------------------
  RCTs                                                                                                                          
  Blank and Smithkline                        1           3             6               Individual           Individual         2
  Boden-Albala *et al*,[@R34] 2015            1           3             6               Individual           Individual         1
  Dracup *et al*,[@R15] 2009                  4           3             6               Individual           Individual         2
  Luepker *et al*,[@R31] 2000                 4           3             6               Community            Both               NA
  Meischke *et al*,[@R32] 1997                4           2             6               Individual           Individual         3
  Mooney *et al*,[@R10] 2014                  4           1             6               Individual           Individual         1
  Müller-Nordhorn *et al*,[@R33] 2009         4           3             6               Community            Community          NA
  Controlled before and after studies                                                                                           
  Morgenstern *et al*,[@R35] 2002             4           3             6               Community            Individual         1
  Rowley *et al*,[@R36] 1982                  4           3             6               Practice             Practice           3
  Xin-gang *et al*,[@R37] 2013                4           3             6               Community            Individual         3
  Uncontrolled before and after studies/ITS                                                                                     
  Addo *et al*,[@R66] 2012                    4           3             6               Community            Individual         NA
  Alberts *et al*,[@R59] 1992                 4           3             6               Individual           Individual         NA
  Barsan *et al*,[@R60] 1994                  4           3             6               Community            Individual         NA
  Bett *et al*,[@R45] 2005                    4           3             6               Community            Individual         NA
  Bett *et al*,[@R46] 1993                    3           3             6               Community            Individual         NA
  Black and Brown,[@R62] 1973                 4           3             6               Community            Individual         NA
  Breuer *et al*,[@R54] 1999                  4           3             6               Community            Individual         NA
  Camerlingo *et al*,[@R64] 2014              4           2             6               Community            Individual         NA
  Diercks *et al*,[@R56] 2010                 4           3             6               Community            Individual         NA
  Gaspoz *et al*,[@R48] 1996                  4           3             6               Community            Individual         NA
  Herlitz *et al*,[@R55] 1992                 2           3             6               Community            Individual         NA
  Ho *et al*,[@R1] 1989                       4           3             6               Community            Individual         NA
  Hodgson *et al*,[@R38] 2007                 4           3             6               Community            Individual         NA
  Luiz *et al*,[@R49] 2001                    4           3             6               Community            Individual         NA
  Maeso-Madronero *et al*,[@R52] 2000         4           3             6               Community            Individual         1
  Mellon *et al*,[@R40] 2014                  4           2             6               Community            Individual         NA
  Mitic and Perkins,[@R57] 1984               4           3             6               Community            Individual         NA
  Moses *et al*,[@R67] 1991                   4           3             6               Community            Individual         NA
  Naegeli *et al*,[@R63] 2011                 4           3             6               Community            Individual         NA
  Nishijima *et al*,[@R65] 2016               4           2             6               Community            Individual         NA
  Rau *et al*,[@R53] 2005                     4           3             6               Community            Individual         1
  Rustige *et al*,[@R41] 1992                 4           3             6               Community            Individual         NA
  Thomassen *et al*,[@R50] 1999               4           3             6               Community            Individual         NA
  Waters *et al*,[@R47] 1983                  4           3             6               Community            Individual         NA
  Wolters *et al*,[@R51] 2015                 4           3             6               Community            Individual         NA
  Wright *et al*,[@R58] 2001                  4           3             6               Community            Individual         NA
  Post-test only studies (n=2)                                                                                                  
  Bray *et al*,[@R44] 2015                    2           2             6               Community            Individual         NA
  Månsson *et al*,[@R43] 1999                 4           3             6               Community            Individual         NA
  Case--control study (n=1)                                                                                                     
  Tummala and Farshid,[@R42] 2015             2           2             6               Community            Individual         NA

ITS, interrupted time series; ITT, intention to treat; NA, not available.

Of the 29 remaining non-randomised studies (23 uncontrolled before and after, 3 ITS, 2 post-test only and 1 case--control), 7[@R38] studies were rated strong on selection bias, that is, included samples judged as likely to be representative of the target population; majority of the remainder rated as moderate or weak (20 moderate; 2 weak). All were rated weak on data collection methods. None received a strong rating on blinding; 25 were rated moderate and 5 as weak.

In describing intervention integrity, the percentage of participants receiving the allocated intervention was reported in 6[@R30] of the 40 studies.

Intervention characteristics {#s3-5}
----------------------------

[Table 4](#T4){ref-type="table"} summarises the characteristics of interventions evaluated in included studies. There was considerable variation in the descriptions of interventions between studies. Although all interventions were directed at patients, 14 studies also included a professional education component. Eleven studies reported a theoretical basis or underlying framework to their interventions, including social marketing principles,[@R44] Leventhal's self-regulatory model,[@R10] Safer's model of patient delay,[@R32] social cognitive theory and principles of motivational interviewing,[@R34] and a combination of self-regulatory model, social cognitive theory, diffusion theory and social marketing and community organisation principles.[@R31]

###### 

Summary table of study and intervention characteristics associated with effectiveness of interventions aimed at reducing patient delay

  Study details                                                                   Total (N)   Significant reduction in patient delay   No significant reduction in patient delay
  ------------------------------------------------------------------------------- ----------- ---------------------------------------- -------------------------------------------
  Study design                                                                                                                         
   RCTs/Cluster RCT                                                               7           2                                        5
   Controlled before and after                                                    3           2                                        1
   Uncontrolled before and after/ITS                                              26          15                                       11
   Post-test only                                                                 2           1                                        1
   Case--control study                                                            1           0                                        0
  Theoretical underpinning                                                                                                             
   Yes                                                                            8           2                                        6
   No                                                                             31          18                                       13
  Intervention mode of delivery                                                                                                        
   Population-level, mass media                                                   30          17                                       13
   Individual-level, face-to-face                                                 4           1                                        3
   Individual-level, direct mailing                                               3           2                                        1
   Both, mass media + direct mailing                                              2           0                                        2
  Intervention intensity                                                                                                               
   Campaigns ≤12 months                                                           15          8                                        7
   Campaigns \>12 months                                                          8           4                                        4
  Population                                                                                                                           
   Confirmed diagnosis                                                            15          8                                        7
   Suspected diagnosis                                                            24          12                                       12
  Year of publication                                                                                                                  
   In/before 2000                                                                 18          10                                       8
   After 2000                                                                     21          10                                       11
  Measurement of delay                                                                                                                 
   Symptom onset to hospital arrival                                              24          12                                       12
   Symptom onset to first seeking help                                            5           1                                        4
   Both                                                                           5           4                                        1
   Not reported                                                                   5           3                                        2
  Clinical context                                                                                                                     
   ACS                                                                            5           3                                        2
   MI                                                                             16          8                                        8
   Stroke                                                                         15          9                                        6
   Breast cancer                                                                  2           0                                        2
   Chest pain                                                                     1           0                                        1
  Overall study quality based on total score                                                                                           
   Randomised studies (total quality score range 6--18; good--poor quality)                                                            
   Scored 6--9                                                                    5           2                                        3
   Scored 10--14                                                                  2           0                                        2
   Scored 15--18                                                                  0           0                                        0
   Non-randomised studies (total quality score range 4--12; good--poor quality)                                                        
   Scored 4--5                                                                    1           0                                        1
   Scored 6--8                                                                    20          13                                       7
   Scored 9--12                                                                   11          5                                        6

ACS, acute coronary syndrome; ITS, interrupted time series; MI, myocardial infarction; RCTs, randomised controlled trials.

### Intervention target and setting {#s3-5-1}

Interventions in 30 studies were population-level education campaigns aimed at the general public, 7[@R10] were individual-level interventions aimed at high-risk individuals, and 2[@R31] involved both elements. All public education campaigns were delivered in the community setting (including mass media, GP practices and pharmacy). Three[@R33] of the individual-level interventions were delivered in the community setting and four[@R10] in the hospital setting. Of the interventions involving both individual-level and population-level components, one[@R32] was delivered in community setting and the other[@R31] in both community and hospital settings.

### Intervention mode of delivery, materials, providers and intensity {#s3-5-2}

All public education interventions were mass media campaigns often using multiple channels to deliver the key intervention message. Nineteen used electronic media (television and radio); 23 used print media (newspapers, magazines, press releases, handbooks, pamphlets, leaflets, books); 4 used digital media (eg, mobile phones, internet, blogs, emails); 7 used outdoor media (eg, billboard, posters); and 13 used face-to-face events on a group basis (eg, public meetings, road shows, informative sessions). The two[@R31] interventions with both population-level and individual-level elements used electronic media and direct mailing; one[@R31] also used face-to-face meetings on an individual and group bases. The most commonly used materials in these campaigns involved television and radio ads/features and posters/flyers/leaflets in public places. The duration of the public education campaigns varied considerably, ranging from 1 week to 48 months (M=14.5 months, SD=14.1); 15 population interventions lasted up to 12 months and 8 lasted between 13 and 48 months. The duration was not reported in nine studies.[@R41] Interventions in four studies were implemented in two or more phases/waves.[@R38]

Three[@R33] of the individual-level interventions were delivered remotely using direct mail (eg, letters/leaflets posted to participants' homes); four[@R10] were delivered face-to-face, one of which also used a directly mailed letter and a phone call as reminder and support[@R10]; and one was delivered in a group format.[@R34] The face-to-face interventions used a variety of materials including action/advisory plans (n=1), stickers (n=2), professional scripts (n=2) and educational video (n=2). Three[@R10] of four face-to-face interventions were provided, once only, by nurses, physicians and the researcher, and lasted an average of 28 min (range 5--40 min, SD=20). The fourth face-to-face intervention[@R34] was provided in a group format, twice, by physicians and health educators, for an unspecified duration. Letters were mailed either by physicians, nurses or the research team over an average duration of 5 months (range 1.5--12 months, SD=5.6).

### Intervention tailoring, modifications and fidelity {#s3-5-3}

Most of the interventions were not personally tailored; only one of the public education campaigns[@R56] was tailored to women aged 40--60 years, two tailored the language of the intervention to a specific ethnic/cultural group,[@R34] and two of the one-to-one interventions[@R15] were tailored to patients' past experiences and life situation. None of the studies described any modifications to the interventions during the course of the study. Six studies, four of public education campaigns[@R31] and two of individual intervention,[@R10] reported assessing fidelity of the intervention. Fidelity of mass media campaigns was assessed in terms of the likely reach and impact of the campaign, for example, by obtaining measures of intervention exposure, viewer ratings and random sample surveys of knowledge, attitudes and beliefs. Of the two individual intervention trials, only Mooney *et al* [@R10] reported optimising fidelity through delivery of standardised training to providers and monthly reviews of intervention delivery and data collection procedures. Dracup *et al* [@R15] reported assessing fidelity by measuring knowledge, attitudes and beliefs about ACS in both groups at baseline and follow-up.

Behaviour change techniques {#s3-6}
---------------------------

A total of 19 BCTs from BCTT V.1 and 5 additional techniques were identified across all 39 intervention descriptions. An average of 2 BCTs (SD=2.3, range 0--10) and 2 additional techniques per intervention (SD=0.69, range 0--4) were coded. The most frequently presented BCTs were action planning (n=27), information about health consequences (n=16), problem-solving (n=6), credible source (n=5) and prompts/cues (n=5), and the most frequently used additional techniques were provision of information on signs and symptoms (n=36) and instruction on what to do (n=32) ([table 5](#T5){ref-type="table"}).

###### 

Distribution of BCTs among studies of effective and ineffective interventions (n=39)

  BCT number   BCT label                                                         Frequency   Effective studies in which this BCT is present, n (out of 20)   Ineffective studies in which this BCT is present, n (out of 19)
  ------------ ----------------------------------------------------------------- ----------- --------------------------------------------------------------- -----------------------------------------------------------------
  1.1          Goal-setting (behaviour)                                          1           1                                                               0
  1.2          Problem-solving                                                   6           3                                                               3
  1.4          Action planning                                                   27          14                                                              13
  3.1          Social support (unspecified)                                      2           1                                                               1
  3.2          Social support (practical)                                        3           1                                                               2
  4.1          Instruction on how to perform the behaviour                       4           1                                                               3
  4.2          Information about antecedents                                     1           0                                                               1
  5.1          Information about health consequences                             16          8                                                               8
  5.2          Salience of consequences                                          4           1                                                               3
  6.1          Demonstration of the behaviour                                    3           0                                                               3
  7.1          Prompts and cues                                                  5           3                                                               2
  8.1          Behavioural practice/rehearsal                                    3           1                                                               2
  8.2          Behaviour substitution                                            1           1                                                               0
  9.1          Credible source                                                   5           3                                                               2
  11.2         Reduce negative emotions                                          1           0                                                               1
  12.5         Adding objects to the environment                                 3           2                                                               1
  13.1         Identification of self as a role model                            1           0                                                               1
  13.2         Framing/Reframing                                                 1           1                                                               0
  15.1         Verbal persuasion about capability                                1           0                                                               1
               Additional techniques                                                                                                                         
  AT1          Provision of factual information (eg, on signs and symptoms)      36          18                                                              18
  AT2          Instruction on behaviour (what to do)                             32          17                                                              15
  AT3          Instruction on intermediate behaviour                             1           0                                                               1
  AT4          Information about health consequences of intermediate behaviour   1           0                                                               1
  AT5          Reflecting on past experiences                                    1           1                                                               0

BCTs, behaviour change techniques.

Reported intervention effectiveness {#s3-7}
-----------------------------------

Just over half (n=20)[@R10] the studies reported a statistically significant reduction in delay following intervention, 2 of which were RCTs,[@R10] while the remaining 19[@R1] did not, including 5 RCTs.[@R15]

Associations between reported intervention effectiveness and various study features {#s3-8}
-----------------------------------------------------------------------------------

### BCTs and effectiveness {#s3-8-1}

A visual inspection of the distribution of effective and ineffective studies on individual BCTs suggests no clear pattern of association between the presence of individual BCTs and reported intervention effectiveness. The majority of the BCTs were equally likely to be present in studies reporting a positive effect on patient delay as those reporting no effect (see [table 5](#T5){ref-type="table"} and [figures 4 and 5](#F4 F5){ref-type="fig"}). There was no relationship between the number of BCTs present and intervention effectiveness (point-biserial r=−0.086, p=0.602, n=39).

![BCTs and effectiveness.](openhrt-2018-000975f04){#F4}

![Additional techniques and effectiveness.](openhrt-2018-000975f05){#F5}

### Intervention and study characteristics, methodological quality and effectiveness {#s3-8-2}

Visual inspection of the distribution of studies reporting significant and non-significant effects of intervention on various study and intervention features ([table 4](#T4){ref-type="table"}) suggests absence of a clear pattern of association between reported intervention effectiveness and the examined study/intervention characteristics. Similarly [table 6](#T6){ref-type="table"} suggests absence of a clear pattern of association between reported intervention effectiveness and methodological quality.

###### 

Summary table of overall methodological quality ratings associated with intervention effectiveness

  Author and year                                     EPHPP global rating   Total score   Did intervention reduce patient delay significantly?
  --------------------------------------------------- --------------------- ------------- ------------------------------------------------------
  RCTs (n=7)                                                                              
   Blank and Smithkline                               3                     12/18         No
   Boden-Albala *et al*,[@R34] 2015                   1                     8/18          No
   Dracup *et al*,[@R15] 2009                         2                     8/18          No
   Luepker *et al*,[@R31] 2000                        2                     9/18          No
   Meischke *et al*,[@R32] 1997                       3                     11/15         No
   Mooney *et al*,[@R10] 2014                         1                     7/18          Yes
   Müller-Nordhorn *et al*,[@R33] 2009                2                     8/18          Yes
  Controlled before and after studies (n=3)                                               
   Morgenstern *et al*,[@R35] 2002                    NA                    6/12          No
   Rowley *et al*,[@R36] 1982                         NA                    10/12         Yes
   Xin-gang *et al*,[@R37] 2013                       NA                    9/12          Yes
  Uncontrolled before and after studies /ITS (n=26)                                       
   Addo *et al*,[@R66] 2012                           NA                    9/12          No
   Alberts *et al*,[@R59] 1992                        NA                    9/12          Yes
   Barsan *et al*,[@R60] 1994                         NA                    9/12          Yes
   Bett *et al*,[@R45] 2005                           NA                    9/12          No
   Bett *et al*,[@R46] 1993                           NA                    10/12         No
   Black and Brown,[@R62] 1973                        NA                    9/12          Yes
   Breuer *et al*,[@R54] 1999                         NA                    8/12          Yes
   Camerlingo *et al*,[@R64] 2014                     NA                    9/12          Yes
   Diercks *et al*,[@R56] 2010                        NA                    10/12         No
   Gaspoz *et al*,[@R48] 1996                         NA                    10/12         Yes
   Herlitz *et al*,[@R55] 1992                        NA                    9/12          Yes
   Ho *et al*,[@R1] 1989                              NA                    10/12         No
   Hodgson *et al*,[@R38] 2007                        NA                    8/12          Yes
   Luiz *et al*,[@R49] 2001                           NA                    8/12          Yes
   Maeso-Madronero *et al*,[@R52] 2000                NA                    9/12          Yes
   Mellon *et al*,[@R40] 2014                         NA                    9/12          No
   Mitic and Perkins,[@R57] 1984                      NA                    9/12          Yes
   Moses *et al*,[@R67] 1991                          NA                    9/12          No
   Naegeli *et al*,[@R63] 2011                        NA                    9/12          Yes
   Nishijima *et al*,[@R65] 2016                      NA                    9/12          Yes
   Rau *et al*,[@R53] 2008                            NA                    8/12          No
   Rustige *et al*,[@R41] 1992                        NA                    9/12          Yes
   Thomassen *et al*,[@R50] 1999                      NA                    10/12         No
   Waters *et al*,[@R47] 1983                         NA                    8/12          No
   Wolters *et al*,[@R51] 2015                        NA                    9/12          Yes
   Wright *et al*,[@R58] 2001                         NA                    8/12          No
  Post-test only (n=2)                                                                    
   Bray *et al*,[@R44] 2015                           NA                    10/12         Yes
   Månsson *et al*,[@R43] 1999                        NA                    11/12         No
  Case--control study (n=1)                                                               
   Tummala and Farshid,[@R42] 2015                    NA                    9/12          No

EPHPP, Effective Public Health Practice Project; ITS, interrupted time series; NA, not available; RCTs, randomised controlled trials.

Findings specific to studies measuring patient delay {#s3-9}
----------------------------------------------------

Ten studies[@R36] assessed patient delay, that is, the time from symptom onset to first medical contact distinct from other aspects of prehospital delay (eg, transportation time).

Of the ten studies which measured patient delay, none were RCTs, one[@R36] was a controlled before and after study, seven[@R45] were uncontrolled before and after, and two[@R43] single-group post-test design. Eight[@R45] evaluated mass media interventions and two direct mail educational interventions.[@R36] The most commonly used techniques were techniques additional to BCTT V.1: all (10/10) studies which measured patient delay included *AT1 Provision of factual information* (eg, on signs and symptoms) and almost all (9/10) included *AT2 Instruction on behaviour (what to do*). The results are presented in [table 7](#T7){ref-type="table"}, and it can be seen that there is no clear pattern of association between the presence of a particular technique and a reduction in patient delay. However, three[@R36] of the four studies,[@R36] which included two or more BCTs in addition to the commonly used AT1 and AT2, reported a significant reduction in patient delay.

###### 

BCTs and additional techniques used in effective and ineffective studies measuring patient delay (n=10)

  BCT number   BCT label                                                                 Frequency   Effective studies in which this BCT is present, n (n=5)   Ineffective studies in which this BCT is present, n (n=5)
  ------------ ------------------------------------------------------------------------- ----------- --------------------------------------------------------- -----------------------------------------------------------
  1.1          Goal-setting (behaviour)                                                  0           0                                                         0
  1.2          Problem-solving                                                           1           1                                                         0
  1.4          Action planning                                                           6           3                                                         3
  3.1          Social support (unspecified)                                              0           0                                                         0
  3.2          Social support (practical)                                                0           0                                                         0
  4.1          Instruction on how to perform the behaviour                               1           1                                                         0
  4.2          Information about antecedents                                             0           0                                                         0
  5.1          Information about health consequences                                     4           2                                                         2
  5.2          Salience of consequences                                                  2           1                                                         1
  6.1          Demonstration of the behaviour                                            0           0                                                         0
  7.1          Prompts and cues                                                          1           1                                                         0
  8.1          Behavioural practice/rehearsal                                            0           0                                                         0
  8.2          Behaviour substitution                                                    0           0                                                         0
  9.1          Credible source                                                           2           2                                                         0
  11.2         Reduce negative emotions                                                  0           0                                                         0
  12.5         Adding objects to the environment                                         1           1                                                         0
  13.1         Identification of self as a role model                                    0           0                                                         0
  13.2         Framing/Reframing                                                         0           0                                                         0
  15.1         Verbal persuasion about capability                                        0           0                                                         0
               Additional techniques                                                                                                                           
  AT1          Provision of factual information (eg, on signs and symptoms of disease)   10          5                                                         5
  AT2          Instruction on behaviour (what to do)                                     9           5                                                         4
  AT3          Instruction on intermediate behaviour                                     0           0                                                         0
  AT4          Information about health consequences of intermediate behaviour           0           0                                                         0
  AT5          Reflecting on past experiences                                            0           0                                                         0

BCTs, behaviour change techniques.

Findings specific to ACS studies {#s3-10}
--------------------------------

Of the five studies that evaluated an intervention to reduce patient delay in ACS, two[@R10] were RCTs and two[@R56] were uncontrolled before and after studies, and one was a post-test-only study.[@R44] One of each design[@R10] reported a significant reduction in patient delay following intervention. The two RCTs[@R10] evaluated an individual-level intervention delivered face-to-face in a clinical setting. The two before and after studies[@R56] and one post-test-only study[@R44] evaluated a population-level mass media campaign aimed at reducing patient delay for symptoms of ACS. The most commonly used BCTs and additional techniques were action planning (n=4) and provision of information on signs and symptoms of disease (n=4), respectively. The results are summarised in [table 8](#T8){ref-type="table"}, and visual inspection suggests no pattern of association between the presence of a technique and reported effectiveness.

###### 

BCTs and additional techniques used in effective and ineffective studies in ACS (n=5)

  --------------------------------------------------------------------------------------------------------------------------------------------------
  BCT number   BCT label                                                                 Frequency   Effective ACS\          Ineffective\
                                                                                                     studies in which\       ACS studies in\
                                                                                                     this BCT is\            which this BCT is\
                                                                                                     present, n (out of 3)   present, n (out of 2)
  ------------ ------------------------------------------------------------------------- ----------- ----------------------- -----------------------
  1.1          Goal-setting (behaviour)                                                  1           1                       0

  1.2          Problem-solving                                                           6           2                       1

  1.4          Action planning                                                           27          3                       1

  3.1          Social support (unspecified)                                              2           1                       0

  3.2          Social support (practical)                                                3           1                       1

  4.1          Instruction on how to perform the behaviour                               4           1                       0

  4.2          Information about antecedents                                             1           0                       1

  5.1          Information about health consequences                                     16          2                       1

  5.2          Salience of consequences                                                  4           0                       1

  6.1          Demonstration of the behaviour                                            3           0                       0

  7.1          Prompts and cues                                                          5           1                       1

  8.1          Behavioural practice/rehearsal                                            3           1                       1

  8.2          Behaviour substitution                                                    1           1                       0

  9.1          Credible source                                                           5           1                       0

  11.2         Reduce negative emotions                                                  1           0                       0

  12.5         Adding objects to the environment                                         3           0                       0

  13.1         Identification of self as a role model                                    1           0                       0

  13.2         Framing/reframing                                                         1           0                       1

  15.1         Verbal persuasion about capability                                        1           0                       0

               Additional techniques                                                                                         

  AT1          Provision of factual information (eg, on signs and symptoms of disease)   36          3                       1

  AT2          Instruction on behaviour (what to do)                                     33          3                       0

  AT3          Instruction on intermediate behaviour                                     1           0                       0

  AT4          Information about health consequences of intermediate behaviour           1           0                       0

  AT5          Reflecting on past experiences                                            1           1                       0
  --------------------------------------------------------------------------------------------------------------------------------------------------

ACS, acute coronary syndrome; BCTs, behaviour change techniques.

Discussion {#s4}
==========

This comprehensive and systematic review of the existing literature in relation to reducing patient delay with serious symptoms has found that only around half of the studied interventions report any success in reducing prehospital delay. This proportion is similar across study designs, mode of delivery, populations and clinical contexts. This demonstrates there is still much scope to improve the effectiveness of interventions to reduce delay. Despite examining a number of components that might explain the variation in effectiveness, we were unable to differentiate the studies reporting success from those that did not. This is true even if only the subset of studies conducted in a cardiac population are examined, and therefore the conclusions reflect a limitation of the available literature in this area and are not related to the scope of the review. When we considered only studies that measured patient delay distinct from other aspects of prehospital delay (ie, those best suited to answering our question), there is some evidence to suggest that additional use of BCTs might be helpful, but further robust enquiry is required to confirm this finding.

We have identified and described the behaviour change components of interventions to reduce patient delay. Action planning, information about health consequences and problem-solving were the most frequently used BCTs. However, techniques not currently classified as BCTs in BCTT V.1[@R19] were identified more commonly than the most common BCTs: information on signs and symptoms and instruction on what to do. This suggests there is scope to increase the use of BCTT V.1 techniques in interventions to reduce delay.

Unfortunately, missing and highly skewed data prevented us from being able to conduct the desired meta-analyses to explore whether particular techniques are associated with effective interventions. We also encountered some difficulties in applying BCTT V.1 to BCTs delivered by mass media to public health campaigns. Possible adjustments to BCTT V.1 have been suggested via the online feedback portal: <https://www.ucl.ac.uk/behaviour-change-techniques> [/BCTTv1Feedback](/BCTTv1Feedback).

In common with previous attempts to systematically review behaviour change interventions, the quality of intervention reporting was mixed.[@R69] It is difficult to identify BCTs in poorly described interventions, although still possible to achieve reliability between coders.[@R71] Techniques were described in reports using terms similar to the labels used in the taxonomy but with descriptions that differed from those provided by BCTT V.1. For example, 'action planning' occurred in interventions, but the accounts mostly described linking symptoms with specific actions and plans being given to patients rather than actively involving them in planning. This reinforces the urgent need for the 'common language' and unambiguous definitions provided by BCTT V.1[@R19] to ensure when interventions or components of interventions are described or reviewed that it is possible to compare like with like.

Guidelines have been produced in efforts to improve reporting standards,[@R26] and as journals begin to require authors to adhere to these (eg, <http://www.journals.elsevier.com/social-science-and-medicine/policies>) intervention descriptions are likely to improve. Thus, in time, it will likely become easier to extract information about BCTs in reviews and for the purposes of secondary analysis. In the meantime, sole reliance on systematic reviews of evidence produced prior to such guidance to identify potentially useful BCTs in interventions is fraught with difficulty and may be best supplemented with other transparent, systematic methods (eg, we undertook an expert consensus study in parallel).

Limitations {#s4-1}
-----------

This review is limited as it only assesses published materials. Despite our best efforts, described in the search strategy section (above) to obtain additional information from authors and the 'grey literature', we did not identify data suitable for inclusion in the review that had not been published. There is thus the potential that publication bias has resulted in studies with negative findings being less likely to be identified.[@R72]

Some methodological problems were encountered during the course of this review, which we outline briefly to inform future reviews in this area. Difficulties were encountered judging the methodological quality of some studies due to the nature of study designs---for example, before and after assessments carried out in different people; in RCTs, assessments of intervention consistency and fidelity are difficult in public health campaigns; and judgements about contamination or cointervention are next to impossible, particularly in studies of public health campaigns. Future study designers should be cognisant of these issues and authors must ensure complete reporting. There may be scope for methodological advances to be made in relation to assessing public health campaign data for meta-analysis.

We were unable to locate guidance on how to determine the EPHPP global quality score, which is weighted for the number of high/poor quality ratings, when one or more dimensions are not applicable. Although we were able to find examples of approaches other authors had taken,[@R73] detailed guidance would help ensure a consistent approach and facilitate robust comparisons between studies.

Conclusion {#s5}
==========

This review has found that only half of the interventions to reduce prehospital delay with time-critical symptoms report significantly reduced delay times. Some limited evidence suggests that additional use of BCTs might be helpful in reducing patient delay in particular. The BCTs most commonly identified within interventions are *action planning*, *information about health consequences* and *problem-solving*, plus the additional techniques identified as *information on signs and symptoms* and *instruction on what to do*. However we were unable to establish if any particular BCT differentiates effective interventions from non-effective interventions. Much remains to be done to understand how to effectively influence patient decision time. The task will be expedited if researchers use consistent measures of decision time, provide comprehensive intervention descriptions and use agreed definitions of BCTs.
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